Amit MICHAELI,Immanuel LERNER,Anke BURGER-KENTISCHER,Steffen RUPP
申请号：
US15998974
公开号：
US20200247849A1
申请日:
2017.02.16
申请国别(地区):
US
年份:
2020
代理人:
摘要：
A group of peptides is provided which activate or inhibit toll-like receptor 4 (TLR4) and may be used to modulate inflammatory signaling and host defense pathways. The peptides were derived in silico and tested in vitro in cell cultures. These peptides may be used in the preparation of immunomodulatory compositions such as vaccine adjuvants and in pharmaceutical compositions for immunomodulation of the innate immune system such as vaccine adjuvants. The peptides may also be used in the preparation of TLR4 activators, TLR4 inhibitors and MD2 labels, e.g., for research purposes.
